Recognized as a major risk factor for GDM by leading guidelines, PCOS confers risk through synergistic mechanisms: pre-pregnancy IR compounded by pregnancy-induced hormonal changes (estrogen, progesterone, placental lactogen) that further impair insulin sensitivity (41–43). This evidence concerns the gene INS and polycystic ovary syndrome.